| scholarly article | Q13442814 |
| P50 | author | Corey T McMillan | Q59563247 |
| Leo McCluskey | Q115277346 | ||
| Jenny Russ | Q38802663 | ||
| P2093 | author name string | Murray Grossman | |
| David J Irwin | |||
| Edward B Lee | |||
| Lauren Elman | |||
| Elisabeth M Wood | |||
| Vivanna Van Deerlin | |||
| P2860 | cites work | Classification of primary progressive aphasia and its variants | Q24594803 |
| Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia | Q24598142 | ||
| Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion | Q39408417 | ||
| Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations | Q46986726 | ||
| Hypermethylation of the CpG-island near the C9orf72 G₄C₂-repeat expansion in FTLD patients. | Q48726618 | ||
| Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. | Q51868850 | ||
| Effect of TMEM106B polymorphism on functional network connectivity in asymptomatic GRN mutation carriers | Q86957861 | ||
| Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics | Q24630362 | ||
| Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features | Q24630410 | ||
| Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS | Q24633692 | ||
| A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD | Q24634583 | ||
| Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain | Q25855787 | ||
| Nonparametric permutation tests for functional neuroimaging: a primer with examples | Q28211607 | ||
| The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier) | Q28485924 | ||
| A reproducible evaluation of ANTs similarity metric performance in brain image registration | Q28741589 | ||
| Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions. | Q30570437 | ||
| The power of neuroimaging biomarkers for screening frontotemporal dementia | Q33934175 | ||
| Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients | Q34037076 | ||
| C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD. | Q34167443 | ||
| Regional brain changes in aging healthy adults: general trends, individual differences and modifiers | Q34392779 | ||
| Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family | Q34472281 | ||
| Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72 | Q34500097 | ||
| Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain | Q34656983 | ||
| Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier | Q34810486 | ||
| Cognitive reserve in granulin-related frontotemporal dementia: from preclinical to clinical stages | Q34990333 | ||
| Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. | Q35776914 | ||
| The Philadelphia Brief Assessment of Cognition (PBAC): a validated screening measure for dementia | Q35814014 | ||
| Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study | Q35859698 | ||
| Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion | Q36464731 | ||
| Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis | Q36527483 | ||
| Multiparametric MRI study of ALS stratified for the C9orf72 genotype | Q37170150 | ||
| Stages of pTDP-43 pathology in amyotrophic lateral sclerosis | Q37202139 | ||
| Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood | Q37316040 | ||
| MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration | Q37350681 | ||
| Development and validation of pedigree classification criteria for frontotemporal lobar degeneration | Q37531130 | ||
| Sparse canonical correlation analysis relates network-level atrophy to multivariate cognitive measures in a neurodegenerative population | Q37547899 | ||
| Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration. | Q37652962 | ||
| The neuropathology associated with repeat expansions in the C9ORF72 gene | Q38172839 | ||
| Basal ganglia involvement in amyotrophic lateral sclerosis | Q39318107 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neuroimaging | Q551875 |
| hypermethylation | Q106875739 | ||
| P304 | page(s) | 1622-1630 | |
| P577 | publication date | 2015-03-20 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | C9orf72 promoter hypermethylation is neuroprotective: Neuroimaging and neuropathologic evidence | |
| P478 | volume | 84 |
| Q33791480 | A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD |
| Q50295667 | A comparative bioinformatic analysis of C9orf72. |
| Q38860456 | ALS and FTD: an epigenetic perspective |
| Q93184542 | Amyotrophic lateral sclerosis - a multisystem neurodegenerative disorder |
| Q60046457 | Biomarkers for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Associated With Hexanucleotide Expansion Mutations in |
| Q36600364 | C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells |
| Q64948055 | C9orf72-mediated ALS and FTD: multiple pathways to disease. |
| Q42727057 | Cognitive reserve in frontotemporal degeneration: Neuroanatomic and neuropsychological evidence |
| Q90165868 | DNA methylation and brain structure and function across the life course: A systematic review |
| Q39107075 | Disease Mechanisms of C9ORF72 Repeat Expansions |
| Q86822232 | Frontotemporal Dementia |
| Q36880235 | Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs |
| Q90182692 | Genetic predictors of survival in behavioral variant frontotemporal degeneration |
| Q38789426 | Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions |
| Q37497445 | Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype |
| Q64917154 | Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression. |
| Q40055403 | Neuron loss and degeneration in the progression of TDP-43 in frontotemporal lobar degeneration |
| Q99241367 | Neuronal Transcriptome from C9orf72 Repeat Expanded Human Tissue is Associated with Loss of C9orf72 Function |
| Q51762990 | Occupational attainment influences longitudinal decline in behavioral variant frontotemporal degeneration. |
| Q37736146 | Opening up the DNA methylome of dementia |
| Q26782984 | Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia |
| Q33746283 | RNA metabolism in neurodegenerative disease. |
| Q40415783 | The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter |
| Q51165295 | The Genetics of C9orf72 Expansions. |
| Q38826893 | The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease |
| Q26750577 | There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS |
| Q64075393 | Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS |
| Q35752114 | Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease |
| Q89763818 | Widespread loss of the silencing epigenetic mark H3K9me3 in astrocytes and neurons along with hippocampal-dependent cognitive impairment in C9orf72 BAC transgenic mice |
Search more.